SEC Company Response from Innoviva, Inc. (INVA) (CIK 0001080014) (INVA) — Mar 7, 2017
Innoviva, Inc. (INVA) (CIK 0001080014)
Date: March 7, 2017 · CIK: 0001080014 · Accession: 0001104659-17-014592
AI Filing Summary & Sentiment
Letter
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP
FOUR TIMES SQUARE
DIRECT DIAL
212-735-2116
DIRECT FAX
917-777-2116
EMAIL ADDRESS
RICHARD.GROSSMAN@SKADDEN.COM
NEW YORK 10036-6522
TEL: (212) 735-3000
FAX: (212) 735-2000
www.skadden.com
March 7, 2017
FIRM/AFFILIATE OFFICES
BOSTON
CHICAGO
HOUSTON
LOS ANGELES
PALO ALTO
WASHINGTON, D.C.
WILMINGTON
BEIJING
BRUSSELS
FRANKFURT
HONG KONG
LONDON
MOSCOW
MUNICH
PARIS
SÃO PAULO
SEOUL
SHANGHAI
SINGAPORE
TOKYO
TORONTO
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
RE: Innoviva, Inc. Preliminary Proxy Materials
Ladies and Gentlemen:
On behalf Innoviva, Inc., a Delaware corporation (the “Company”), and pursuant to the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, enclosed please find via EDGAR a copy of the preliminary proxy statement and form of proxy card relating to the 2017 annual meeting of the Company’s stockholders (the “2017 Annual Meeting”), which comments on and refers to a potential solicitation in opposition to the Company’s solicitation at the 2017 Annual Meeting.
If you have any questions or require additional information concerning the enclosed materials, please call me at (212) 735-2116 or email me at richard.grossman@skadden.com or please call Jay K. Hachigian at (617) 648-9101 or email at hach@gunder.com.
Thank you.
Very truly yours,
/s/ Richard J. Grossman
Show Raw Text
CORRESP
1
filename1.htm
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP
FOUR TIMES SQUARE
DIRECT DIAL
212-735-2116
DIRECT FAX
917-777-2116
EMAIL ADDRESS
RICHARD.GROSSMAN@SKADDEN.COM
NEW YORK 10036-6522
TEL: (212) 735-3000
FAX: (212) 735-2000
www.skadden.com
March 7, 2017
FIRM/AFFILIATE OFFICES
BOSTON
CHICAGO
HOUSTON
LOS ANGELES
PALO ALTO
WASHINGTON, D.C.
WILMINGTON
BEIJING
BRUSSELS
FRANKFURT
HONG KONG
LONDON
MOSCOW
MUNICH
PARIS
SÃO PAULO
SEOUL
SHANGHAI
SINGAPORE
TOKYO
TORONTO
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
RE: Innoviva, Inc.
Preliminary Proxy Materials
Ladies and Gentlemen:
On behalf Innoviva, Inc., a Delaware corporation (the “Company”), and pursuant to the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, enclosed please find via EDGAR a copy of the preliminary proxy statement and form of proxy card relating to the 2017 annual meeting of the Company’s stockholders (the “2017 Annual Meeting”), which comments on and refers to a potential solicitation in opposition to the Company’s solicitation at the 2017 Annual Meeting.
If you have any questions or require additional information concerning the enclosed materials, please call me at (212) 735-2116 or email me at richard.grossman@skadden.com or please call Jay K. Hachigian at (617) 648-9101 or email at hach@gunder.com.
Thank you.
Very truly yours,
/s/ Richard J. Grossman
Richard J. Grossman
Enclosures
cc: Michael W. Aguiar
President and Chief Executive Officer
Innoviva, Inc.
Eric d’Esparbes
Senior Vice President and Chief Financial Officer
Innoviva, Inc.
Jay K. Hachigian
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP
Keith J. Scherer
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP
Richard J. Grossman
Skadden, Arps, Slate, Meagher and Flom LLP
Amr Razzak
Skadden, Arps, Slate, Meagher and Flom LLP